HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

YiQiFuMai lyophilized injection attenuates cerebral ischemic injury with inhibition of neuronal autophagy through intervention in the NMMHC IIA-actin-ATG9A interaction.

AbstractBACKGROUND:
YiQiFuMai lyophilized injection (YQFM) is derived from a traditional Chinese medicine prescription termed Shengmai San.YQFM is clinically applied to the treatment of cardiovascular and cerebrovascular diseases. It has been found that critical components of YQFM affect non-muscle myosin heavy chain IIA (NMMHC IIA), but its regulation in the excessive autophagy and the underlying mechanism has yet to be clarified.
PURPOSE:
To evaluate whether YQFM has neuroprotective effects on cerebral ischemia/reperfusion-induced injury by inhibiting NMMHC IIA-actin-ATG9A interaction for autophagosome formation.
METHODS:
The neuroprotective effects of YQFM were investigated in vivo in mice with middle cerebral artery occlusion/reperfusion (MCAO/R) (n = 6) by detecting neurological deficits, infarct volume, and histopathological changes. The NMMHC IIA-actin-ATG9A interaction was determined using immunofluorescence co-localization, co-immunoprecipitation, and proximity ligation assay. Rat pheochromocytoma (PC12) cells subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) were used to mimic neurons in in vitro experiments.
RESULTS:
In MCAO/R model mice, YQFM (1.342 g/kg) attenuated brain ischemia/reperfusion-induced injury by regulating NMMHC IIA-actin-mediated ATG9A trafficking. YQFM (400 μg/ml) also exerted similar effects on OGD/R-induced PC12 cells. Furthermore, RNAi of NMMHC IIA weakened the NMMHC IIA-F-actin-dependent ATG9A trafficking and, therefore, attenuated the neuroprotective activities of YQFM in vitro.
CONCLUSION:
These findings demonstrated that YQFM exerted neuroprotective effects by regulating the NMMHC IIA-actin-ATG9A interaction for autophagosome formation. This evidence sheds new light on the potential mechanism of YQFM in the treatment of cerebral ischemia/reperfusion.
AuthorsLinjie Su, Yining Liu, Huifen Ma, Fan Zheng, Yujie Daia, Tiezheng Wang, Guangyun Wang, Fang Li, Yuanyuan Zhang, Boyang Yu, Shuaishuai Gong, Junping Kou
JournalPhytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 95 Pg. 153882 (Jan 2022) ISSN: 1618-095X [Electronic] Germany
PMID34968897 (Publication Type: Journal Article)
CopyrightCopyright © 2021. Published by Elsevier GmbH.
Chemical References
  • ATG9A protein, rat
  • Actins
  • Atg9A protein, mouse
  • Autophagy-Related Proteins
  • Drugs, Chinese Herbal
  • Membrane Proteins
  • Neuroprotective Agents
  • Vesicular Transport Proteins
  • yi-qi-fu-mai
Topics
  • Actins
  • Animals
  • Autophagy
  • Autophagy-Related Proteins
  • Brain Ischemia (drug therapy)
  • Drugs, Chinese Herbal (pharmacology)
  • Membrane Proteins
  • Mice
  • Neuroprotective Agents (pharmacology)
  • Rats
  • Reperfusion Injury (drug therapy)
  • Vesicular Transport Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: